ArticleNature communications2023

PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer.

Yunxing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.